- US12612443utility2026Cell0 cites
- US12496314utility2025Antigen-binding Domain0 cites
- US12492410utility2025Engineered Cytolytic Immunecell0 cites
- US12454578utility2025Cytolytic Immune Cell Comprising BCMA- and Cd19-specific Chimeric Antigen Receptors0 cites
- US12398194utility2025Cell Lexpressing Two Chimeric Antigen Receptors (cars) at the Cell Surface0 cites
- US12325733utility2025Binding Domain0 cites
- US12269860utility2025Compositions and Methods Comprising Engineered Chimeric Antigen Receptor and Modulator of CAR0 cites
- US12241068utility2025Cd79-specific Chimeric Antigen Receptor0 cites
- US12241124utility2025Molecular Assessment of TRBC Usage0 cites
- US12187769utility2025Cell0 cites
- US12049510utility2024Chimeric Antigen Receptor0 cites
- US11982672utility2024Methods0 cites
- US11982673utility2024Methods0 cites
- US11963981utility2024Chimeric Antigen Receptor0 cites
- US11965173utility2024Plasmid System0 cites
- US11959084utility2024Nucleic Acid Construct0 cites
- US11945867utility2024T-cell Receptor Constant Region 1 Antibody or T-cell Receptor Constant Region 2 Antibody0 cites
- US11903967utility2024Method of Preparing T Cells with Increased Activity0 cites
Page 1 of 2Next →